Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Benhabbour RS. Study of Imidazole-Based Proton-Conducting Composite Materials Using Solid-State NMR. Chemistry of materials : a publication of the American Chemical Society. 2005; 17(6):1605-1612. doi: 10.1021/cm048301l.
Benhabbour SR. Synthesis and characterization of carborane functionalized dendronized polymers as potential BNCT agents. Abstracts of Papers. 232nd ACS National Meeting; 2006 September 10; San Fransisco, CA, USA. PMSE-171; c2006.
Benhabbour RS. Synthesis and Properties of Carborane-Containing Dendronized Polymers. Macromolecules. 2007; 40(16):5678-5688. doi: 10.1021/ma0702039.
Benhabbour RS. Protein Resistance of Surfaces Prepared by Chemisorption of Monothiolated Poly(ethylene glycol) to Gold and Dendronization with Aliphatic Polyester Dendrons: Effect of Hydrophilic Dendrons. Macromolecules. 2008; 41(7):2567–2576. doi: 10.1021/ma702074v.
Benhabbour RS. Protein Resistance of Surfaces Prepared by Chemisorption of Mono-Thiolated Poly(ethylene glycol) to Gold and Dendronization with Aliphatic Polyester Dendrons: Effect of Hydrophilic Dendron. Macromolecules. 2008; 41(7):2567-2576. doi: 10.1021/ma8004586.
Benhabbour RS. Synthesis and Characterization of Carborane Functionalized Dendronized Polymers as Potential BNCT Agents. ACS symposium series. American Chemical Society. 2008; 977:238-249. doi: 35400018371493.0140.
Benhabbour SR. Synthesis and characterization of Carborane functionalized Dendronized polymers as potential boron neutron capture therapy agents. In: Polymers for Biomedical Applications USA: ACS Symposium Series; 2008. Chapter 14; p.238-249.
Benhabbour SR, Sheardown H, Adronov A. Cell adhesion and proliferation on hydrophilic dendritically modified surfaces. Biomaterials. 2008 Nov;29(31):4177-86. doi: 10.1016/j.biomaterials.2008.07.016. Epub 2008 Aug 3. PubMed PMID: 18678405.
Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, Valliant JF, Adronov A. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J Am Chem Soc. 2009 Mar 4;131(8):2906-16. doi: 10.1021/ja8078175. PubMed PMID: 19239268.
Benhabbour SR. Engineering of lipid-based nanoparticles with accessible nickel for binding to his-tag protein and antigens. Abstracts of Papers. 239th ACS National Meeting; 2010 March 21; San Fransisco, CA, USA. PMSE-410; c2010.
Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo. Int J Nanomedicine. 2011;6:2545-56. doi: 10.2147/IJN.S24954. Epub 2011 Oct 21. PubMed PMID: 22072889; PubMed Central PMCID: PMC3205148.
Benhabbour SR. Targeting of docetaxel-loaded lipid based nanoparticles to breast cancer using a novel trimeric ZEGFR domain. Abstracts of Papers. 243rd ACS National Meeting & Exposition; 2012 March 25; San Diego, CA, USA. PMSE-256; c2012.
Benhabbour SR, Luft JC, Kim D, Jain A, Wadhwa S, Parrott MC, Liu R, DeSimone JM, Mumper RJ. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. J Control Release. 2012 Feb 28;158(1):63-71. doi: 10.1016/j.jconrel.2011.10.013. Epub 2011 Oct 20. PubMed PMID: 22037106; PubMed Central PMCID: PMC3294062.
Ma P, Rahima Benhabbour S, Feng L, Mumper RJ. 2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer. Cancer Lett. 2013 Jul 1;334(2):253-62. doi: 10.1016/j.canlet.2012.08.009. Epub 2012 Aug 16. PubMed PMID: 22902506; PubMed Central PMCID: PMC3522796.
Feng L, Benhabbour SR, Mumper RJ. Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer. Adv Healthc Mater. 2013 Nov;2(11):1451-7. doi: 10.1002/adhm.201300017. Epub 2013 Apr 19. PubMed PMID: 23606545; PubMed Central PMCID: PMC3858483.
Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ. 2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model. Int J Nanomedicine. 2014;9:3601-10. doi: 10.2147/IJN.S66040. eCollection 2014. PubMed PMID: 25114529; PubMed Central PMCID: PMC4124067.
Peng L, Feng L, Yuan H, Benhabbour SR, Mumper RJ. Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles. Nanomedicine. 2014 Oct;10(7):1497-506. doi: 10.1016/j.nano.2014.03.016. Epub 2014 Apr 4. PubMed PMID: 24709328; PubMed Central PMCID: PMC4185254.
Benhabbour SR. Development and evaluation of CD44-targeted lipid-based nanoparticles in an orthotopic non-small cell lung cancer xenograft mouse model. 249th ACS National Meeting & Exposition; 2015 March 22; Denver, CO, USA. PMSE-258.; c2015.
Glatt DM, Beckford Vera DR, Parrott MC, Luft JC, Benhabbour SR, Mumper RJ. The Interplay of Antigen Affinity, Internalization, and Pharmacokinetics on CD44-Positive Tumor Targeting of Monoclonal Antibodies. Mol Pharm. 2016 Jun 6;13(6):1894-903. doi: 10.1021/acs.molpharmaceut.6b00063. Epub 2016 Apr 28. PubMed PMID: 27079967.
Dunn SS, Beckford Vera DR, Benhabbour SR, Parrott MC. Rapid microwave-assisted synthesis of sub-30nm lipid nanoparticles. J Colloid Interface Sci. 2017 Feb 15;488:240-245. doi: 10.1016/j.jcis.2016.10.093. Epub 2016 Nov 2. PubMed PMID: 27835817; PubMed Central PMCID: PMC5153442.
Kovarova M, Benhabbour SR, Massud I, Spagnuolo RA, Skinner B, Baker CE, Sykes C, Mollan KR, Kashuba ADM, García-Lerma JG, Mumper RJ, Garcia JV. Ultra-long-acting removable drug delivery system for HIV treatment and prevention. Nat Commun. 2018 Oct 8;9(1):4156. doi: 10.1038/s41467-018-06490-w. PubMed PMID: 30297889; PubMed Central PMCID: PMC6175887.
Glatt DM, Beckford Vera DR, Prabhu SS, Mumper RJ, Luft JC, Benhabbour SR, Parrott MC. Synthesis and Characterization of Cetuximab-Docetaxel and Panitumumab-Docetaxel Antibody-Drug Conjugates for EGFR-Overexpressing Cancer Therapy. Mol Pharm. 2018 Nov 5;15(11):5089-5102. doi: 10.1021/acs.molpharmaceut.8b00672. Epub 2018 Oct 1. PubMed PMID: 30226780.
Zhu C, Dukhovlinova E, Council O, Ping L, Faison EM, Prabhu SS, Potter EL, Upton SL, Yin G, Fay JM, Kincer LP, Spielvogel E, Campbell SL, Benhabbour SR, Ke H, Swanstrom R, Dokholyan NV. Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies. Nat Commun. 2019 Feb 27;10(1):948. doi: 10.1038/s41467-019-08876-w. PubMed PMID: 30814513; PubMed Central PMCID: PMC6393580.
Benhabbour SR, Kovarova M, Jones C, Copeland DJ, Shrivastava R, Swanson MD, Sykes C, Ho PT, Cottrell ML, Sridharan A, Fix SM, Thayer O, Long JM, Hazuda DJ, Dayton PA, Mumper RJ, Kashuba ADM, Victor Garcia J. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery. Nat Commun. 2019 Sep 20;10(1):4324. doi: 10.1038/s41467-019-12141-5. PubMed PMID: 31541085; PubMed Central PMCID: PMC6754500.
Janusziewicz R, Mecham SJ, Olson KR, Benhabbour SR. Design and Characterization of a Novel Series of Geometrically Complex Intravaginal Rings with Digital Light Synthesis. Adv Mater Technol. 2020 Aug;5(8). doi: 10.1002/admt.202000261. Epub 2020 Jun 23. PubMed PMID: 33072856; PubMed Central PMCID: PMC7567335.
Maturavongsadit P, Paravyan G, Shrivastava R, Benhabbour S. Thermo-/pH-responsive chitosan-cellulose nanocrystals based hydrogel with tunable mechanical properties for tissue regeneration applications. Materialia. 2020 August; 12(100681).
Prasher A, Shrivastava R, Dahl D, Sharma-Huynh P, Maturavongsadit P, Pridgen T, Schorzman A, Zamboni W, Ban J, Blikslager A, Dellon ES, Benhabbour SR. Steroid Eluting Esophageal-Targeted Drug Delivery Devices for Treatment of Eosinophilic Esophagitis. Polymers (Basel). 2021 Feb 13;13(4). doi: 10.3390/polym13040557. PubMed PMID: 33668571; PubMed Central PMCID: PMC7917669.
Maturavongsadit P, Narayanan LK, Chansoria P, Shirwaiker R, Benhabbour SR. Cell-Laden Nanocellulose/Chitosan-Based Bioinks for 3D Bioprinting and Enhanced Osteogenic Cell Differentiation. ACS Appl Bio Mater. 2021 Mar 15;4(3):2342-2353. doi: 10.1021/acsabm.0c01108. Epub 2021 Feb 17. PubMed PMID: 35014355.
King JL, Benhabbour SR. Glioblastoma Multiforme-A Look at the Past and a Glance at the Future. Pharmaceutics. 2021 Jul 9;13(7). doi: 10.3390/pharmaceutics13071053. Review. PubMed PMID: 34371744; PubMed Central PMCID: PMC8309001.
Young IC, Benhabbour SR. Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy. Polymers (Basel). 2021 Jul 26;13(15). doi: 10.3390/polym13152450. Review. PubMed PMID: 34372059; PubMed Central PMCID: PMC8347890.
Maturavongsadit P, Shrivastava R, Sykes C, Cottrell ML, Montgomery SA, Kashuba AD, Benhabbour S. Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs. International journal of pharmaceutics. 2021 August; 605(120844):1-12.
Maturavongsadit P, Paravyan G, Kovarova M, Garcia JV, Benhabbour SR. A new engineering process of biodegradable polymeric solid implants for ultra-long-acting drug delivery. Int J Pharm X. 2021 Dec;3:100068. doi: 10.1016/j.ijpx.2020.100068. eCollection 2021 Dec. PubMed PMID: 33392498; PubMed Central PMCID: PMC7773589.
Dahl DK, Whitesell AN, Sharma-Huynh P, Maturavongsadit P, Janusziewicz R, Fox RJ, Loznev HT, Button B, Schorzman AN, Zamboni W, Ban J, Montgomery SA, Carey ET, Benhabbour S. A mucoadhesive biodissolvable thin film for localized and rapid delivery of lidocaine for the treatment of vestibulodynia. International Journal of Pharmaceutics. 2022 January; 612(121288):1-16.
Joiner JB, King JL, Shrivastava R, Howard SA, Cottrell ML, Kashuba ADM, Dayton PA, Benhabbour SR. Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant Pharmacokinetics. Pharmaceutics. 2022 Mar 11;14(3). doi: 10.3390/pharmaceutics14030615. PubMed PMID: 35335991; PubMed Central PMCID: PMC8948873.
What would you like to do?
  • Page of 1